Literature DB >> 21116117

Gene promoter methylation and its potential relevance in early prostate cancer diagnosis.

Isabel Steiner1, Klaus Jung, Philipp Schatz, Torsten Horns, Daniel Wittschieber, Michael Lein, Manfred Dietel, Andreas Erbersdobler.   

Abstract

AIMS: We investigated hypermethylation of the glutathione S-transferase pi (GSTP1), retinoic acid receptor β2 (RARβ2), adenomatous polyposis coli (APC) and paired-like homeodomain transcription factor 2 (PITX2) gene promoters which could serve as a sensitive tool to indicate a risk of prostate cancer even in histologically tumor-free tissues.
METHODS: Tumor tissues and non-neoplastic tissues at variable distances from the tumor foci were retrieved from 25 formalin-fixed and paraffin-embedded prostatectomy specimens and subjected to DNA extraction. The methylation levels were assessed by means of different assay technologies.
RESULTS: Significantly increased methylation levels in cancer specimens were found for all promoter regions (GSTP1: 21/25, 84%; RARβ2: 24/25, 96%; APC: 21/25, 84%; PITX2: 20/25, 80%) and in most samples containing prostatic intraepithelial neoplasia. Several samples showed increased RARβ2 and APC methylation in adjacent non-neoplastic tissue. An association between the methylation extent of GSTP1, APC and RARβ2, respectively, and primary Gleason grade was detectable. GSTP1 methylation was also associated with extraprostatic tumor extension.
CONCLUSION: GSTP1, APC, RARβ2 and PITX2 methylation occur frequently in prostate cancer, making these markers sensitive tools for the detection of neoplastic lesions in the prostate. For RARβ2, the results suggest a kind of methylation field effect which could be helpful for the detection of prostate cancer. Larger studies are necessary to investigate a potential correlation of GSTP1, RARβ2 and APC hypermethylation with tumor aggressiveness.
Copyright © 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21116117     DOI: 10.1159/000318017

Source DB:  PubMed          Journal:  Pathobiology        ISSN: 1015-2008            Impact factor:   4.342


  8 in total

1.  Evaluation of GSTP1 and APC methylation as indicators for repeat biopsy in a high-risk cohort of men with negative initial prostate biopsies.

Authors:  Bruce J Trock; Michelle J Brotzman; Leslie A Mangold; Joseph W Bigley; Jonathan I Epstein; David McLeod; Eric A Klein; J Stephen Jones; Songbai Wang; Theresa McAskill; Jyoti Mehrotra; Bhargavi Raghavan; Alan W Partin
Journal:  BJU Int       Date:  2011-11-11       Impact factor: 5.588

2.  ID4 is frequently downregulated and partially hypermethylated in prostate cancer.

Authors:  Anna Vinarskaja; Wolfgang Goering; Marc Ingenwerth; Wolfgang A Schulz
Journal:  World J Urol       Date:  2011-09-01       Impact factor: 4.226

Review 3.  APC gene hypermethylation and prostate cancer: a systematic review and meta-analysis.

Authors:  Yang Chen; Jie Li; Xiaoxiang Yu; Shuai Li; Xuerong Zhang; Zengnan Mo; Yanling Hu
Journal:  Eur J Hum Genet       Date:  2013-01-09       Impact factor: 4.246

4.  Methylation in benign prostate and risk of disease progression in men subsequently diagnosed with prostate cancer.

Authors:  Benjamin A Rybicki; Andrew Rundle; Oleksandr N Kryvenko; Nicoleta Mitrache; Kieu C Do; Michelle Jankowski; Dhananjay A Chitale; Sheri Trudeau; Steven A Belinsky; Deliang Tang
Journal:  Int J Cancer       Date:  2016-03-02       Impact factor: 7.396

5.  Using the epigenetic field defect to detect prostate cancer in biopsy negative patients.

Authors:  Matthew Truong; Bing Yang; Andrew Livermore; Jennifer Wagner; Puspha Weeratunga; Wei Huang; Rajiv Dhir; Joel Nelson; Daniel W Lin; David F Jarrard
Journal:  J Urol       Date:  2012-11-15       Impact factor: 7.450

6.  Methylation of the RARB gene increases prostate cancer risk in black Americans.

Authors:  Deliang Tang; Oleksandr N Kryvenko; Nicoleta Mitrache; Kieu C Do; Michelle Jankowski; Dhananjay A Chitale; Sheri Trudeau; Andrew Rundle; Steven A Belinsky; Benjamin A Rybicki
Journal:  J Urol       Date:  2013-01-30       Impact factor: 7.450

7.  DNA methylation changes correlate with Gleason score and tumor stage in prostate cancer.

Authors:  Lissette Delgado-Cruzata; Gregory W Hruby; Karina Gonzalez; James McKiernan; Mitchel C Benson; Regina M Santella; Jing Shen
Journal:  DNA Cell Biol       Date:  2011-08-10       Impact factor: 3.550

8.  The association between histone 3 lysine 27 trimethylation (H3K27me3) and prostate cancer: relationship with clinicopathological parameters.

Authors:  Marjolaine Ngollo; Andre Lebert; Aslihan Dagdemir; Gaelle Judes; Seher Karsli-Ceppioglu; Marine Daures; Jean-Louis Kemeny; Frederique Penault-Llorca; Jean-Paul Boiteux; Yves-Jean Bignon; Laurent Guy; Dominique Bernard-Gallon
Journal:  BMC Cancer       Date:  2014-12-23       Impact factor: 4.430

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.